Brokerages Set AdaptHealth Corp. (NASDAQ:AHCO) Price Target at $11.67

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $11.67.

AHCO has been the subject of a number of recent research reports. Truist Financial cut their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Robert W. Baird reduced their target price on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Canaccord Genuity Group decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. UBS Group dropped their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada decreased their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $9.52 on Thursday. The company has a market cap of $1.28 billion, a P/E ratio of -5.77, a P/E/G ratio of 1.36 and a beta of 1.10. AdaptHealth has a 52-week low of $6.46 and a 52-week high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm’s fifty day moving average is $9.96 and its two-hundred day moving average is $10.38.

AdaptHealth (NASDAQ:AHCO) last posted its earnings results on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The firm had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. AdaptHealth’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.19 earnings per share. As a group, analysts anticipate that AdaptHealth will post 0.88 EPS for the current fiscal year.

Institutional Trading of AdaptHealth

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board purchased a new position in shares of AdaptHealth during the second quarter valued at approximately $58,000. Quarry LP increased its stake in AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after purchasing an additional 5,838 shares during the period. Innealta Capital LLC bought a new stake in shares of AdaptHealth during the second quarter worth $101,000. Quest Partners LLC lifted its position in shares of AdaptHealth by 11,522.7% during the second quarter. Quest Partners LLC now owns 10,228 shares of the company’s stock worth $102,000 after purchasing an additional 10,140 shares during the last quarter. Finally, CIBC Asset Management Inc purchased a new stake in shares of AdaptHealth during the third quarter valued at $122,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.